Table 3 Cox proportional hazard ratios for CYP2C19*2 and CYP2C19*17 genotypes and Disease Free Survival.

From: CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset

Comparison

Hazard Ratio (95% CI); (N)

CYP2C19*2

Genotypes

No *2 allele

1.0 (Reference); (971)

*2/*1

1.05 (0.78–1.42); (420)

*2/*2

0.79 (0.32–1.94); (54)

CYP2C19*17

Genotypes

No *17 allele

1.0 (Reference); (609)

*17/*1

1.02 (0.71–1.46); (361)

*17/*17

0.57 (0.26–1.24); (71)

Back to article page